Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Eli Lilly’s lebrikizumab significantly improves atopic dermatitis in Phase III trial

August 16, 2021 Sales and Marketing

Eli Lilly’s lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase III trials. …
News

Health Canada accepts rolling submission for Merck’s experimental COVID therapy

August 16, 2021 Sales and Marketing

Merck has begun its rolling submission to Health Canada for its experimental antiviral agent, molnupiravir, as a potential COVID-19 therapy. …
News
pfizer

Australia buys Pfizer vaccines from Poland amid record COVID infections

August 16, 2021 Sales and Marketing

Australia has purchased around 1 million Pfizer vaccines from Poland as the country battles a wave of infections. Australian Prime …
News

Researchers develop new method to kill bacteria on medical implants

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …
News

‘Potential’ link between vaccines and menstruation changes

August 9, 2021 Sales and Marketing

France’s health body has said changes in women’s menstrual cycles are a “potential” side effect of receiving the Moderna or …
News

Psoriasis treatment bimekizumab maintains high Levels of skin clearance

August 9, 2021 Sales and Marketing

New two-year data has shown that bimekizumab maintained high Levels of skin clearance in patients with moderate to severe plaque …
News
az

First new adult CDK treatment in 20 years gains UK and EU approval

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …
News

FDA approves Nexviazyme as treatment for late-onset Pompe disease

August 9, 2021 Sales and Marketing

The FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset …
News
az

Sierra Oncology to licence myelofibrosis candidate from AstraZeneca

August 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …
News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
News
img_4190-e1376666350337-web

Pulse oxygen monitors less effective on darker skin, MHRA warns

August 2, 2021 Sales and Marketing

The MHRA has warned that pulse oxygen monitors, devices designed to spot early signs of dangerous falls in oxygen levels …
News

BioMed X to research autoimmune diseases and drug delivery with Janssen

August 2, 2021 Sales and Marketing

BioMed X Institute is to start two new research programs in the field of autoimmune diseases and drug delivery in …
News

Republican report says COVID-19 leaked from Chinese lab

August 2, 2021 Sales and Marketing

A report released by the US Republican party on Monday has concluded that the virus that caused the COVID-19 pandemic …
News

Double jabbed from EU and US no longer need to quarantine in UK

August 2, 2021 Sales and Marketing

Arrivals to the UK from the EU and US no longer have to quarantine if they have been double jabbed …
News

Pfizer and Moderna hike vaccine prices in EU

August 2, 2021 Sales and Marketing

Pfizer and Moderna have raised the prices of their COVID-19 vaccines in the EU, as reported in the Financial Times.Pfizer-BioNTech …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025